Allelica fosters research and medical communities,
enabling them to generate, validate and integrate
the genetic risk factor in common disease prevention.
Read more →
For Clinical
Genetics Labs
Embrace data-driven healthcare prevention. Offer world class PRS for clinical grade risk prediction.
For Researchers
Generate the best performing PRS using cutting-edge algorithms in parallel. Validate PRS on multiple populations with just two clicks.
For Pharmas
Improve the power of clinical trials by stratifying participants based on genomic diversity. Explore opportunities for drug repurposing.
Allelica is partnering with Merck, a leading global healthcare and life sciences company, to develop a suite of data-driven cardiovascular disease prevention tools.
“With this agreement, Merck confirms its strong commitment in advancing Science and Technology in the therapeutic area of cardiovascular disorders.”
Antonio Messina, Merck General Manager
Read more →Latest news
Genomic Medicine Virtual Conference
Rady Children's Institute for Genomic Medicine Virtual Conference 2020, Integrating Genomic Medicine Across Systems, will dive deep into the latest innovations in genomic medicine. We will show our work alongside leaders in research and healthcare on how early polygenic risk score testing can reduce the lifetime risk of coronary artery disease.
ASHG Virtual Meeting
We are proud to have been selected as a “Reviewer's Choice” by the American Society of Human Genetics,being rated among the top 10% of abstracts. Our work will be presented at the ASHG Virtual Meeting 2020 where researchers will come together to present their latest discoveries and explore new tools & technologies to transform genomic medicine.
16th World Congress of Public Health
We are very excited to announce our participation in the 16th World Congress of Public Health, a conference which brings together some of the brightest minds and latest scientific developments from across the globe. Our presentation will focus on the role of polygenic risk scores in the prevention of common adult onset conditions.Our Principles
Data Driven
Our products are developed and validated using world class datasets and state-of-the-art technology to ensure the highest level of quality.
Scientific Rigor
We are a group of international scientists and researchers committed to maintaining standards of academic excellence every step of the way.
Human-centricity
Everything we do works towards our common goal of providing tangible improvement in preventive healthcare to help humans live a longer, healthier life.
What we do
Perform genetic risk analysis
Allelica's Polygenic Risk Scores for common diseases have the highest predictive power on the market, allowing physicians to more effectively help patients lower their risk of life-threatening diseases.
Power research communities
Our secure digital platform enables researchers to construct and validate new Polygenic Risk Scores on multiple populations using the top algorithms in parallel to reveal the best Polygenic Risk Scores.
Funded by:
European body
for innovation in Health
Seed fund
